Literature DB >> 7216432

Heterotypic immunity to influenza in ferrets.

R A Yetter, W H Barber, P A Small.   

Abstract

Heterotypic immunity to influenza virus in ferrets operated against heterotypic influenza viruses but not heterologous viruses. Contrary to prior reports, the protection conferred lasted for at least 18 months. This type of immunity limited virus shedding but did not prevent infection. These results suggest that this phenomenon could play a role in determining the severity of infections caused by type A influenza viruses in humans.

Entities:  

Mesh：

Year:  1980        PMID： 7216432      PMCID： PMC551176          DOI： 10.1128/iai.29.2.650-653.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  7 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Studies with avian influenza A viruses: cross protection experiments in chickens.

Authors:  W H Allan; C R Madeley; A P Kendal
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

3.  Influenza infection in ferrets: role of serum antibody in protection and recovery.

Authors:  P A Small; R H Waldman; J C Bruno; G E Gifford
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

4.  Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines.

Authors:  C McLaren; C W Potter
Journal:  J Hyg (Lond)       Date:  1974-02

5.  Dissemination of influenza virus between anatomically isolated sites in ferrets.

Authors:  W H Barber; P A Small
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

6.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

Authors:  R A Yetter; S Lehrer; R Ramphal; P A Small
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490
  7 in total
  21 in total

1.  The reinfection threshold regulates pathogen diversity: the case of influenza.

Authors:  Dinis Gökaydin; José B Oliveira-Martins; Isabel Gordo; M Gabriela M Gomes
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

2.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Andrew T Gewirtz; Sang-Moo Kang
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

Review 4.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

5.  Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.

Authors:  M C Steinhoff; L F Fries; R A Karron; M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.

Authors:  Y Okuno; K Matsumoto; Y Isegawa; S Ueda
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 7.  Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Authors:  Suzanne L Epstein
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

8.  Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Geert van Amerongen; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Nella J Nieuwkoop; Peter van Run; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

9.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Authors:  Suzanne L Epstein; Terrence M Tumpey; Julia A Misplon; Chia-Yun Lo; Lynn A Cooper; Kanta Subbarao; Mary Renshaw; Suryaprakash Sambhara; Jacqueline M Katz
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

10.  Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

Authors:  Jean-Michel Garcia; Stephanie Pepin; Nadège Lagarde; Edward S K Ma; Frederick R Vogel; Kwok H Chan; Susan S S Chiu; J S M Peiris
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.